Why Is Senti Biosciences Stock Surging Over 400% On Monday? Senti Biosciences shares surge as SENTI-202 trial shows promise in AML patients; company secures $37.6M in private equity funding.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday Pre-market stock movers are worth diving into this morning as we break down all of the biggest news moving shares on Tuesday!
Senti Biosciences (SNTI) Stock Is Up Over 100%: What's Happening? Senti Biosciences shares are trading higher by 102.6% during Monday's session. The company was awarded $8 million from the California Institute for Regenerative Medicines.
Why Is Beyond Air (XAIR) Stock Down 22% Today? Beyond Air stock is down on Tuesday as investors in XAIR react to the company mixed earnings report for the first quarter of the year.
Why Is Faraday Future (FFIE) Stock Down 27% Today? Faraday Future stock is down on Tuesday after the troubled EV company announced plans for a reverse split of FFIE shares.
Why Is Senti Biosciences (SNTI) Stock Up 32% Today? Senti Biosciences stock is up on Tuesday with heavy pre-market trading of SNTI shares despite a lack of news from the company.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday Pre-market stock movers are worth checking out on Tuesday as we get into all of the hottest news worth reading about this morning!
SNTI Stock Earnings: Senti Biosciences Misses EPS for Q4 2023 SNTI stock results show that Senti Biosciences missed analyst estimates for earnings per share the fourth quarter of 2023.
Why Is Blood Cancer Focused Senti Biosciences Stock Trading Higher Today? Senti Biosciences Inc (
NASDAQ: SNTI ) received FDA clearance for its Investigational New Drug (IND) application for SENTI-202, an off-the-shelf chimeric antigen receptor natural killer (CAR-NK) cell therapy product candidate designed to selectively target and eliminate CD33 and/or FLT3 expressing hemato
